RT Journal Article
SR Electronic
T1 Predictive usefulness of PCR testing in different patterns of Covid-19 symptomatology - Analysis of a French cohort of 12,810 outpatients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.07.20124438
DO 10.1101/2020.06.07.20124438
A1 AP-HP / Universities / Inserm COVID-19 research collaboration members
A1 Apra Caroline
A1 Caucheteux Charlotte
A1 Mensch Arthur
A1 Mansour Jenny
A1 Bernaux Mélodie
A1 Dechartres Agnès
A1 Debuc Erwan
A1 Lescure Xavier
A1 Dinh Aurélien
A1 Yordanov Youri
A1 Jourdain Patrick
A1 Mensch Arthur
A1 Caucheteux Charlotte
A1 Apra Caroline
A1 Mansour Jenny
A1 Paris Nicolas
A1 Gramfort Alexandre
YR 2020
UL http://medrxiv.org/content/early/2020/06/09/2020.06.07.20124438.abstract
AB Polymerase Chain reaction (PCR) is a key tool to diagnose Covid-19. Yet access to PCR is often limited. In this paper, we develop a clinical strategy for prescribing PCR to patients based on data from COVIDOM, a French cohort of 54,000 patients with clinically suspected Covid-19 including 12,810 patients tested by PCR. Using a machine learning algorithm (a decision tree), we show that symptoms alone are sufficient to predict PCR outcome with a mean average precision of 86%. We identify combinations of symptoms that are predictive of PCR positivity (90% for anosmia/ageusia) or negativity (only 30% of PCR+ for a subgroup with cardiopulmonary symptoms): in both cases, PCR provides little added diagnostic value. We deduce a prescribing strategy based on clinical presentation that can improve the global efficiency of PCR testing.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNot a clinical trialFunding StatementThe authors declare no specific funding for this study. COVIDOM received funding by the Programme Hospitalier de Recherche Clinique 2020 of the French Ministry of Health, by a research fund by APHP-Fondation de France and from the EIT Health specific Covid-19 fund. Arthur Mensch was funded by ERC grant Noria.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Approved by the Scientific and ethical committee of APHP (IRB00011591), Paris, FranceAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData and code available on request for academic researchers